{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:14:52Z","timestamp":1790072092114,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.yebeh.2015.04.034","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T20:36:59Z","timestamp":1437597419000},"page":"76-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Drug-induced status epilepticus"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5656-0141","authenticated-orcid":false,"given":"Hannah R.","family":"Cock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2-3","key":"10.1016\/j.yebeh.2015.04.034_bb0005","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eplepsyres.2010.07.015","article-title":"The uncommon causes of status epilepticus: a systematic review","volume":"91","author":"Tan","year":"2010","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0010","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.yebeh.2015.04.034_bb0015","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/15563650.2013.811588","article-title":"Misuse of the Naranjo Adverse Drug Reaction Probability Scale in toxicology","volume":"51","author":"Seger","year":"2013","journal-title":"Clin Toxicol"},{"issue":"12","key":"10.1016\/j.yebeh.2015.04.034_bb0020","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1345\/aph.1D202","article-title":"The quality of published adverse drug event reports","volume":"37","author":"Kelly","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.yebeh.2015.04.034_bb0025","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2015.04.034_bb0030","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cll.2006.01.009","article-title":"Chemically induced seizures","volume":"26","author":"Wills","year":"2006","journal-title":"Clin Lab Med"},{"issue":"1","key":"10.1016\/j.yebeh.2015.04.034_bb0035","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s13181-010-0096-4","article-title":"Risk factors for complications of drug-induced seizures","volume":"7","author":"Thundiyil","year":"2011","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.yebeh.2015.04.034_bb0040","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/brain\/awl047","article-title":"Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy","volume":"129","author":"Thomas","year":"2006","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.yebeh.2015.04.034_bb0045","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1528-1157.2000.tb00258.x","article-title":"Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine","volume":"41","author":"Osorio","year":"2000","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0050","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0387-7604(99)00113-8","article-title":"When antiepileptic drugs aggravate epilepsy","volume":"22","author":"Genton","year":"2000","journal-title":"Brain Dev"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0055","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jocn.2004.03.027","article-title":"Tiagabine-induced generalised non convulsive status epilepticus in patients with lesional focal epilepsy","volume":"12","author":"Vinton","year":"2005","journal-title":"J Clin Neurosci"},{"issue":"10","key":"10.1016\/j.yebeh.2015.04.034_bb0060","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/j.1528-1167.2005.00263.x","article-title":"Status epilepticus and tiagabine therapy revisited","volume":"46","author":"Koepp","year":"2005","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0065","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.yebeh.2013.02.016","article-title":"Tiagabine-induced stupor in patients with psychogenic nonepileptic seizures: nonconvulsive status epilepticus or encephalopathy?","volume":"27","author":"Azar","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.yebeh.2015.04.034_bb0070","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1212\/01.wnl.0000223336.07466.f3","article-title":"Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy","volume":"67","author":"Jette","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.yebeh.2015.04.034_bb0075","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1212\/01.wnl.0000252370.51970.07","article-title":"Tiagabine-induced myoclonic status epilepticus in a nonepileptic patient","volume":"68","author":"Vollmar","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0080","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/MJT.0b013e31815b04d4","article-title":"Status epilepticus due to tiagabine ingestion","volume":"15","author":"Leikin","year":"2008","journal-title":"Am J Ther"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0085","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.psc.2013.02.004","article-title":"Antidepressant overdose-induced seizures","volume":"36","author":"Judge","year":"2013","journal-title":"Psychiatr Clin North Am"},{"issue":"823","key":"10.1016\/j.yebeh.2015.04.034_bb0090","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/pgmj.70.823.383-b","article-title":"Status epilepticus secondary to fluoxetine","volume":"70","author":"Madi","year":"1994","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.yebeh.2015.04.034_bb0095","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/cap.2000.10.27","article-title":"Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency","volume":"10","author":"Sallee","year":"2000","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0100","first-page":"209","article-title":"Flumazenil \u2014 treatment or toxin","volume":"42","author":"Seger","year":"2004","journal-title":"J Toxicol Clin Exp"},{"issue":"7-8","key":"10.1016\/j.yebeh.2015.04.034_bb0105","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1345\/aph.18399","article-title":"Fatal status epilepticus associated with olanzapine therapy","volume":"33","author":"Wyderski","year":"1999","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.yebeh.2015.04.034_bb0110","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1111\/j.1468-1331.2007.01787.x","article-title":"Status epilepticus associated with sertindole","volume":"14","author":"Sinn","year":"2007","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2015.04.034_bb0115","first-page":"471","article-title":"Lithium overdose causing non-convulsive status epilepticus \u2014 the importance of lithium levels and the electroencephalography in diagnosis","volume":"13","author":"Yip","year":"2007","journal-title":"Hong Kong Med J"},{"issue":"6","key":"10.1016\/j.yebeh.2015.04.034_bb0120","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10072-006-0530-1","article-title":"Non-convulsive status epilepticus during lithium treatment at therapeutic doses","volume":"26","author":"Bellesi","year":"2006","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1528-1167.2010.02924.x","article-title":"Amphetamine-associated seizures: clinical features and prognosis","volume":"52","author":"Brown","year":"2011","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2015.04.034_bb0130","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/BF01709744","article-title":"An unusual case of ecstasy poisoning","volume":"22","author":"Hall","year":"1996","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0135","first-page":"157","article-title":"Cocaine-associated seizures and incidence of status epilepticus","volume":"11","author":"Majlesi","year":"2010","journal-title":"West J Emerg Med"},{"issue":"4","key":"10.1016\/j.yebeh.2015.04.034_bb0140","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0736-4679(94)90345-X","article-title":"Adrenergic crisis from crack cocaine ingestion: report of five cases","volume":"12","author":"Merigian","year":"1994","journal-title":"J Emerg Med"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0145","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00006565-199009000-00006","article-title":"Status epilepticus following the oral ingestion of cocaine in an infant","volume":"6","author":"Conway","year":"1990","journal-title":"Pediatr Emerg Care"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0150","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: management considerations","volume":"72","author":"Grill","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.yebeh.2015.04.034_bb0155","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1345\/aph.1L307","article-title":"Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","volume":"42","author":"Grill","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0160","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0028-3908(03)00188-6","article-title":"Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins","volume":"45","author":"Sugimoto","year":"2003","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.yebeh.2015.04.034_bb0165","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2165\/11587280-000000000-00000","article-title":"Quinolones: review of psychiatric and neurological adverse reactions","volume":"34","author":"Tome","year":"2011","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.yebeh.2015.04.034_bb0170","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00228-010-0887-1","article-title":"Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta","volume":"67","author":"Qiao","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0175","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/08830738030180021101","article-title":"Do not overlook acute isoniazid poisoning in children with status epilepticus","volume":"18","author":"Caksen","year":"2003","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1016\/j.yebeh.2015.04.034_bb0180","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/PEC.0b013e3181db24b6","article-title":"Isoniazid-induced status epilepticus in a pediatric patient after inadequate pyridoxine therapy","volume":"26","author":"Minns","year":"2010","journal-title":"Pediatr Emerg Care"},{"issue":"6","key":"10.1016\/j.yebeh.2015.04.034_bb0185","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1442-200X.2006.02276.x","article-title":"Seizures associated with poisoning in children: tricyclic antidepressant intoxication","volume":"48","author":"Citak","year":"2006","journal-title":"Pediatr Int"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0190","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2169\/internalmedicine.53.1303","article-title":"Convulsive seizures with a therapeutic dose of isoniazid","volume":"53","author":"Tsubouchi","year":"2014","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0195","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jocn.2010.08.014","article-title":"Clarithromycin-induced neurotoxicity in adults","volume":"18","author":"Bandettini di Poggio","year":"2011","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2015.04.034_bb0200","doi-asserted-by":"publisher","first-page":"76","DOI":"10.7326\/0003-4819-123-1-199507010-00021","article-title":"Chloroquine and nonconvulsive status epilepticus","volume":"123","author":"Mulhauser","year":"1995","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0205","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.lungcan.2007.01.012","article-title":"Chemotherapy induced reversible posterior leukoencephalopathy syndrome","volume":"56","author":"Connolly","year":"2007","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0210","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1542\/peds.93.3.511","article-title":"Interferon associated refractory status epilepticus","volume":"93","author":"Miller","year":"1994","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.yebeh.2015.04.034_bb0215","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s004150050086","article-title":"Granulocyte-stimulating: factor filgrastim and molgramostim induced recurring encephalopathy and focal status epilepticus","volume":"244","author":"Kastrup","year":"1997","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2015.04.034_bb0220","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/WNF.0b013e31817f125d","article-title":"Reversible encephalopathy due to sulfasalazine","volume":"31","author":"Mut","year":"2008","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.yebeh.2015.04.034_bb0225","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/08880010390220216","article-title":"Cyclosporin A-associated status epilepticus related to hematopoietic stem cell transplantation for thalassemia","volume":"20","author":"Zakrzewski","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"issue":"12","key":"10.1016\/j.yebeh.2015.04.034_bb0230","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/jnnp.2007.121806","article-title":"Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma","volume":"78","author":"Junna","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0235","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/1550059413500777","article-title":"Ifosfamide chemotherapy and nonconvulsive status epilepticus: case report and review of the literature","volume":"45","author":"Taupin","year":"2014","journal-title":"Clin EEG Neurosci"},{"issue":"1-2","key":"10.1016\/j.yebeh.2015.04.034_bb0240","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jns.2013.10.018","article-title":"Ifosfamide related encephalopathy: the need for a timely EEG evaluation","volume":"336","author":"Feyissa","year":"2014","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.yebeh.2015.04.034_bb0245","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1055\/s-2008-1071410","article-title":"Theophylline and status epilepticus in children","volume":"22","author":"Dunn","year":"1991","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1016\/j.yebeh.2015.04.034_bb0250","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12519-009-0061-y","article-title":"Theophylline-associated status epilepticus in an infant: pharmacokinetics and the risk of suppository use","volume":"5","author":"Kato","year":"2009","journal-title":"World J Pediatr"},{"issue":"5","key":"10.1016\/j.yebeh.2015.04.034_bb0255","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/j.1528-1157.1993.tb02098.x","article-title":"Seizures associated with propofol anaesthesia","volume":"34","author":"Makela","year":"1993","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2015.04.034_bb0260","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.1176\/appi.neuropsych.11110338","article-title":"Status epilepticus associated with dalfampridine in a patient with multiple sclerosis","volume":"24","author":"de Gusmao","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2015.04.034_bb0265","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ana.410360122","article-title":"Baclofen induced generalized nonconvulsive status epilepticus","volume":"36","author":"Zak","year":"1994","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0270","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0987-7053(00)00059-9","article-title":"Nonconvulsive status epilepticus: the role of morphine and its antagonist","volume":"30","author":"Bertran","year":"2000","journal-title":"Clin Neurophysiol"},{"issue":"9","key":"10.1016\/j.yebeh.2015.04.034_bb0275","first-page":"583","article-title":"Convulsive status epilepticus associated with a tramadol overdose","volume":"25","author":"Marquez-Romero","year":"2010","journal-title":"Neurologia"},{"issue":"9","key":"10.1016\/j.yebeh.2015.04.034_bb0280","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1177\/106002809302700921","article-title":"Thyroxine induced partial complex status epilepticus","volume":"27","author":"Duarte","year":"1993","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.yebeh.2015.04.034_bb0285","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3109\/15563650.2010.527850","article-title":"Status epilepticus and wide-complex tachycardia secondary to diphenhydramine overdose","volume":"48","author":"Jang","year":"2010","journal-title":"Clin Toxicol"},{"issue":"4","key":"10.1016\/j.yebeh.2015.04.034_bb0290","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.yebeh.2011.02.017","article-title":"Pseudoephedrine-induced nonconvulsive status epilepticus","volume":"20","author":"Ismailogullari","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.04.034_bb0295","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/B978-0-7020-4087-0.00063-2","article-title":"Neurology and diving","volume":"120","author":"Massey","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"10.1016\/j.yebeh.2015.04.034_bb0300","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.clinthera.2014.09.020","article-title":"Neurotoxicity with antimicrobials in the elderly: a review","volume":"36","author":"Mattappalil","year":"2014","journal-title":"Clin Ther"},{"issue":"8","key":"10.1016\/j.yebeh.2015.04.034_bb0305","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3109\/15563650.2010.521506","article-title":"Should phenytoin or barbiturates be used as second-line anticonvulsant therapy for toxicological seizures?","volume":"48","author":"Shah","year":"2010","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.yebeh.2015.04.034_bb0310","unstructured":"UK Poisons Unit www.toxbase.org. In: Cock H, ed. UK2015."},{"issue":"1","key":"10.1016\/j.yebeh.2015.04.034_bb0400","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF03161033","article-title":"Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System","volume":"3","author":"Thundiyil","year":"2007","journal-title":"J Med Toxicol"},{"issue":"8","key":"10.1016\/j.yebeh.2015.04.034_bb0315","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1177\/08830738050200081201","article-title":"Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents","volume":"20","author":"Marini","year":"2005","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1016\/j.yebeh.2015.04.034_bb0320","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.49.5.1467","article-title":"Vigabatrin aggravates absences and absence status","volume":"49","author":"Panayiotopoulos","year":"1997","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.yebeh.2015.04.034_bb0325","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1177\/08830738060210090801","article-title":"Recurrent absence status epilepticus (spike-and-wave stupor) associated with lamotrigine therapy","volume":"21","author":"Hasan","year":"2006","journal-title":"J Child Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2015.04.034_bb0330","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0387-7604(99)00048-0","article-title":"Myoclonic status epilepticus following high-dosage lamotrigine therapy","volume":"21","author":"Guerrini","year":"1999","journal-title":"Brain Dev"},{"issue":"10","key":"10.1016\/j.yebeh.2015.04.034_bb0335","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1111\/j.1528-1167.2007.01198.x","article-title":"Life-threatening status epilepticus following gabapentin administration in a patient with benign adult familial myoclonic epilepsy","volume":"48","author":"Striano","year":"2007","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.yebeh.2015.04.034_bb0340","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1053\/seiz.1999.0303","article-title":"Tiagabine-induced absence status in idiopathic generalized epilepsy","volume":"8","author":"Knake","year":"1999","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.yebeh.2015.04.034_bb0345","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/j.0013-9580.2004.19704.x","article-title":"Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies","volume":"45","author":"Gelisse","year":"2004","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0350","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1684\/epd.2013.0563","article-title":"Oxcarbazepine-induced myoclonic status epilepticus in juvenile myoclonic epilepsy","volume":"15","author":"Fanella","year":"2013","journal-title":"Epileptic Disord"},{"issue":"1","key":"10.1016\/j.yebeh.2015.04.034_bb0355","first-page":"81","article-title":"Status epilepticus after massive carbamazepine overdose","volume":"40","author":"Spiller","year":"2002","journal-title":"J Toxicol Clin Exp"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0360","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1059-1311(05)80137-2","article-title":"Temporary abolition of seizure activity by flumazenil in a case of valproate-induced non-convulsive status epilepticus","volume":"2","author":"Steinhoff","year":"1993","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0365","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1059-1311(98)80042-3","article-title":"Valproate-induced epileptic tonic status","volume":"7","author":"Capocchi","year":"1998","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0370","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1600-0404.2006.00793.x","article-title":"Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy","volume":"116","author":"Velioglu","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.yebeh.2015.04.034_bb0375","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/WNF.0000000000000020","article-title":"Generalized myoclonus and spasticity induced by lamotrigine toxicity: a case report and literature review","volume":"37","author":"Algahtani","year":"2014","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.yebeh.2015.04.034_bb0380","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1059131102001723","article-title":"A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy","volume":"12","author":"Nakken","year":"2003","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.yebeh.2015.04.034_bb0385","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.yebeh.2005.03.015","article-title":"Nonconvulsive status epilepticus on treatment with levetiracetam","volume":"6","author":"Atefy","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0390","doi-asserted-by":"publisher","first-page":"479-U227","DOI":"10.4103\/0028-3886.82757","article-title":"Paradoxical seizures and status epilepticus with newer antiepileptic drugs","volume":"59","author":"Panda","year":"2011","journal-title":"Neurol India"},{"issue":"3","key":"10.1016\/j.yebeh.2015.04.034_bb0395","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.yebeh.2007.06.012","article-title":"Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain","volume":"11","author":"Knake","year":"2007","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015002036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015002036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T04:11:36Z","timestamp":1717992696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505015002036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":80,"alternative-id":["S1525505015002036"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.04.034","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}